More specifically, the invention is directed to compositions of alcaftadine or 6,11dihydro111methyl4piperidinylidene5himidazo2,1b3benazepine3carboxylic acid, as well as methods for using such compositions for the treatment or prevention of ocular inflammation and allergies. Patents by inventor markus theine markus theine has filed for patents to protect the following inventions. The conjunctival epithelium is a nonkeratinized mucosal tissue with mucinsecreting goblet cells and intraepithelial leukocytes. Which patents cover lastacaft, and when can generic versions of lastacaft launch. May, 2020 additional details are available on the alcaftadine profile page. Alcaftadine is an antagonist at three of the histamine receptors 1, 2 and 4. This invention is directed to the treatment or prevention of ocular conditions. The earliest predictable date that a generic version of the drug could become available is november 20, when the first patent expires. Pdf recent patents and emerging therapeutics in the. Lastacaft was eligible for patent challenges on july 28, 2014. During this time neuland has become a preferred and reliable source for leading pharmaceutical companies worldwide. Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Highlights of prescribing information these highlights do. Guidelines for the examination of patent applications. Recent patents and emerging therapeutics in the treatment of allergic. Brand name prescription medications are approved by the u. Alcaftadine r89674 is a h1 histamine receptor antagonist, which is used to prevent eye irritation brought on by allergic conjunctivitistarget. The compound and methods for its preparation are disclosed in u. Ha kung wong practices general intellectual property law with an emphasis on complex patent and trade secret litigation as well as intellectual property transactions and contract. Apr 17, 2018 altans unique intravenous formulation of acetaminophen has been commercialized in europe and numerous other countries over the past 10 years with over 100 million units sold since launch. Data sources include ibm watson micromedex updated 4 may 2020, cerner multum updated 4 may 2020, wolters kluwer updated. Synthetic approaches to the 2011 new drugs sciencedirect. More specifically, the invention is directed to compositions of alcaftadine or 6,11. Article views are the countercompliant sum of full text article downloads since november 2008 both pdf and html across all institutions and individuals. Appendix t patent cooperation treaty and regulations under the pct done at washington on june 19, 1970, amended on september 28, 1979, modified on february 3, 1984, and october 3, 2001 as in force.
Us 8,826,019 b2 page 2 56 references cited 20070174905 a1 72007 martherus et a1. Global patent litigation dataset by dartsip is licensed under a creative commons attribution 4. Once absorbed, alcaftadine is metabolized by noncyp450 enzymes to an active metabolite, carboxylic acid. The invention relates to new and improved processes for the preparation of alcaftadine and pharmaceutically acceptable salts thereof as well as an intermediate for the preparation of alcaftadine. H1 histamine receptoralcaftadine is a broadspectrum antihistamine displaying a high affinity for histamine h1 and h2 receptors and a lower affinity for h4 receptors. Alcaftadine drug monograph pediatric care online aap. Appendix t patent cooperation treaty and regulations under the pct done at washington on june 19, 1970, amended on september 28, 1979, modified on february 3, 1984, and october 3, 2001 as in force from april 1, 2002 table of contents 1. Alcaftadine also outperformed olopatadine clinically in a series of evaluations. This listing includes patent applications that are pending as well as patents that have. Fda has made the determination because of the submission of an application to the director of patents and trademarks, department. There is one patent protecting this drug and one paragraph iv challenge. Lastacaft is a drug marketed by allergan and is included in one nda. The invention relates to new and improved processes for the preparation of alcaftadine and pharmaceutically acceptable salts thereof as well as an intermediate for the preparation of.
A successful patent application always requires thorough search. Altans unique intravenous formulation of acetaminophen has been commercialized in europe and numerous other countries over the past 10 years with over 100 million units sold since. Alcaftadine alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. Ocular allergy treatments with alcaftadine download pdf. Ocular itch associated with allergic conjunctivitis. It may be more beneficial to use less toxic agents for patients with ocular surface risk factors or presumed symptoms of toxicity. World class pharma ingredients our core business and operational expertise has, for over 3 decades, been the manufacturing and marketing of active pharmaceutical ingredients apis.
The generic ingredient in lastacaft is alcaftadine. Design patents, patent patents, pregrant publications, reissues, and statutory invention registrations are all included. Research paper 52 tackling the proliferation of patents. Alcaftadine is an efficacious multiple action antiallergic therapeutic agent with inverse agonist. Ophthalmic alcaftadine comes as a solution liquid to instill in the eye. Food and drug administration and may be covered by legal patents that delay the availability of lower cost generic substitutes. This effect on histamine receptors seems to show lower rates of itching, eosinophil recruitment and redness after exposure to an allergen. H1 histamine receptoralcaftadine is a broadspectrum. It is usually instilled in the affected eyes once a day. Distribution the protein binding of alcaftadine and the active metabolite are 39. Altan pharma announces the grant of two patents by the. Observermasked trial comparing efficacy of topical olopatadine 0.
Alcaftadine ophthalmic for the eyes is used to prevent itching in the eyes caused by allergies. The main metabolite of alcaftadine is a carboxylic acid metabolite that has minimal. Feb 28, 2008 alcaftadine, also known by the chemical name 6,11dihydro111methyl4piperidinylidene5himidazo 2,1b 3benzazepine3carboxaldehyde, has the following chemical formula. At this time, patents prevent a generic lastacaft alcaftadine product from being manufactured. Ha kung wong practices general intellectual property law with an emphasis on complex patent and trade secret litigation as well as intellectual property transactions and contract negotiations for mergers, acquisitions, vendor agreements and collaborations in pharmaceuticals, biologics, chemistry and medical devices. Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof. Always consult your doctor or healthcare specialist before changing any medicines. I a process for the preparation of an oral pharmaceutical composition of nateglinide, the process comprising.
The protein binding of alcaftadine and carboxylic acid are 39. Alcaftadine is typically administrated as an eye drop which keeps its effects regional as compared to systemic effects. This drug has fortythree patent family members in twentynine countries. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.
These metrics are regularly updated to reflect usage leading up to the last few days. Additional details are available on the alcaftadine profile page. Apparel class 2 baths, closets, sinks, and spittoons class 4 compound tools class 7 bleaching and dyeing. Ocular itching is the pathognomonic symptom of ac, enabling its differential diagnosis from other ocular conditions arising. Multiple patents can be obtained by separating requests with a semicolon. Until longterm safety data are available, the use of oral cladribine would primarily be as an escalating therapy in patients with breakthrough disease on ifn.
Update and clinical utility of alcaftadine ophthalmic. Metabolism the metabolism of alcaftadine is mediated by noncyp450 cytosolic enzymes to the active carboxylic acid metabolite. The invention provides a preparation method of 6,11dihydro111methyl4subpiperidyl5himidazole2,1b3 benzo azepine shown in a formula i. The earliest predictable date that a generic version of the drug could become available is november 20.
Lastacaft, alcaftadine drug patent expiration, 21st nov 20. To help you remember to use alcaftadine, use it around the same time every day. Update and clinical utility of alcaftadine ophthalmic solution 0. Lastacaft alcaftadine ophthalmic solution side effects. After a few days, the palace guards rush breathless into the court, lit with alarm.
Cladribine in the treatment of multiple sclerosis open access. Alcaftadine, allergic conjunctivitis, bepotastine, olopatadine. Federal register volume 83, number 28 friday, february 9, 2018 notices pages 57855786 from the federal register online via the government publishing office. The portuguese had anchored off the malabar coast and were received with warmth by the zamorin. The new process saves a number of steps compared to the known process and results in a higher yield. Comparison of cytotoxicities and antiallergic effects of. By blocking these three receptors, alcaftadine has been shown to significantly reduce the effects of allergens. Alcaftadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Lastacaft alcaftadine dose, indications, adverse effects. Introductory provisions article 1 establishment of a union article 2 definitions.
This material is provided for educational purposes only. The conjunctivae are highly vascularized and immunologically active semitransparent mucous membranes that line the globe. Us anda litigation and generic entry outlook for lastacaft. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be december 23, 2027. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Alcaftadine reference guide for safe and effective use from the american. This listing includes patent applications that are pending as well as patents that have already been granted by the united states patent and trademark office uspto. You agree to cooperate fully with the aap for the purpose of securing, reserving and protecting the aaps rights in such items. Full text update and clinical utility of alcaftadine ophthalmic.
Ocular allergy treatments with alcaftadine vistakon. Alcaftadiner89674 is a h1 histamine receptor antagonist, which is used to prevent eye irritation brought on by allergic conjunctivitistarget. The preparation method comprises the following steps of. Citations are the number of other articles citing this article, calculated by crossref and updated daily. Histamine can produce symptoms such as itchy or watery eyes. Alcaftadine, also known by the chemical name 6,11dihydro111methyl4piperidinylidene5himidazo 2,1b 3benzazepine3carboxaldehyde, has the following chemical. Food and drug administration in 2010 under the trade name lastacaft. It can be accessed through the europa server european commission.
Allergic conjunctivitis ac has an increasing prevalence worldwide. To help you remember to use alcaftadine, use it around the same time. The main metabolite of alcaftadine is a carboxylic acid metabolite that has minimal systemic effects. The main indication for alcaftadine is for prevention of allergic conjunctivitis. Patents listed in the fda orange book drug database of alcaftadine with information and expiryexpiration dates. Appendix t patent cooperation treaty and regulations under. Dec 14, 2017 what is alcaftadine ophthalmic lastacaft.
1145 1105 1460 847 1265 376 56 1293 1455 916 294 67 104 942 1221 650 743 802 348 892 519 871 350 1309 231 1287 227 117 1449 1148 450 695 747 237 639 1275 1377 558 1185 453 378 622 923 709 856 1036